Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Point of Care Infectious Disease market report explains the definition, types, applications, major countries, and major players of the Point of Care Infectious Disease market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Siemens Healthineers
F Hoffmann-La Roche Ltd
Bio-Rad Labs Inc
OJ-Bio Ltd
Thermo Fisher Scientific Inc
bioMérieux SA
BD & Company
Alere
Chembio Diagnostics Inc
Trivitron Healthcare
Quest Diagnostics Inc
Cardinal Health
Gene POC
Sight Diagnostics Ltd
Ortho-Clinical Diagnostics
Trinity Biotech
By Type:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
By End-User:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Point of Care Infectious Disease Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Point of Care Infectious Disease Outlook to 2028- Original Forecasts
-
2.2 Point of Care Infectious Disease Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Point of Care Infectious Disease Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Point of Care Infectious Disease Market- Recent Developments
-
6.1 Point of Care Infectious Disease Market News and Developments
-
6.2 Point of Care Infectious Disease Market Deals Landscape
7 Point of Care Infectious Disease Raw Materials and Cost Structure Analysis
-
7.1 Point of Care Infectious Disease Key Raw Materials
-
7.2 Point of Care Infectious Disease Price Trend of Key Raw Materials
-
7.3 Point of Care Infectious Disease Key Suppliers of Raw Materials
-
7.4 Point of Care Infectious Disease Market Concentration Rate of Raw Materials
-
7.5 Point of Care Infectious Disease Cost Structure Analysis
-
7.5.1 Point of Care Infectious Disease Raw Materials Analysis
-
7.5.2 Point of Care Infectious Disease Labor Cost Analysis
-
7.5.3 Point of Care Infectious Disease Manufacturing Expenses Analysis
8 Global Point of Care Infectious Disease Import and Export Analysis (Top 10 Countries)
-
8.1 Global Point of Care Infectious Disease Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Point of Care Infectious Disease Export by Region (Top 10 Countries) (2017-2028)
9 Global Point of Care Infectious Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Point of Care Infectious Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HIV POC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Clostridium difficile POC Consumption and Growth Rate (2017-2022)
-
9.1.3 Global HBV POC Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pneumonia or Streptococcus associated infections Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Respiratory syncytial virus (RSV) POC Consumption and Growth Rate (2017-2022)
-
9.1.6 Global HPV POC Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Influenza/Flu POC Consumption and Growth Rate (2017-2022)
-
9.1.8 Global HCV POC Consumption and Growth Rate (2017-2022)
-
9.1.9 Global MRSA POC Consumption and Growth Rate (2017-2022)
-
9.1.10 Global TB and drug-resistant TB POC Consumption and Growth Rate (2017-2022)
-
9.2 Global $Point of Care Infectious Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Assisted Living Healthcare Facilities Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Point of Care Infectious Disease Market Analysis and Outlook till 2022
-
10.1 Global Point of Care Infectious Disease Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Point of Care Infectious Disease Consumption (2017-2022)
-
10.2.2 Canada Point of Care Infectious Disease Consumption (2017-2022)
-
10.2.3 Mexico Point of Care Infectious Disease Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.2 UK Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.3 Spain Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.4 Belgium Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.5 France Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.6 Italy Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.7 Denmark Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.8 Finland Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.9 Norway Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.10 Sweden Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.11 Poland Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.12 Russia Point of Care Infectious Disease Consumption (2017-2022)
-
10.3.13 Turkey Point of Care Infectious Disease Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.2 Japan Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.3 India Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.4 South Korea Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.5 Pakistan Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.6 Bangladesh Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.7 Indonesia Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.8 Thailand Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.9 Singapore Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.10 Malaysia Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.11 Philippines Point of Care Infectious Disease Consumption (2017-2022)
-
10.4.12 Vietnam Point of Care Infectious Disease Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.2 Colombia Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.3 Chile Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.4 Argentina Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.5 Venezuela Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.6 Peru Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.7 Puerto Rico Point of Care Infectious Disease Consumption (2017-2022)
-
10.5.8 Ecuador Point of Care Infectious Disease Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Point of Care Infectious Disease Consumption (2017-2022)
-
10.6.2 Kuwait Point of Care Infectious Disease Consumption (2017-2022)
-
10.6.3 Oman Point of Care Infectious Disease Consumption (2017-2022)
-
10.6.4 Qatar Point of Care Infectious Disease Consumption (2017-2022)
-
10.6.5 Saudi Arabia Point of Care Infectious Disease Consumption (2017-2022)
-
10.6.6 United Arab Emirates Point of Care Infectious Disease Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Point of Care Infectious Disease Consumption (2017-2022)
-
10.7.2 South Africa Point of Care Infectious Disease Consumption (2017-2022)
-
10.7.3 Egypt Point of Care Infectious Disease Consumption (2017-2022)
-
10.7.4 Algeria Point of Care Infectious Disease Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Point of Care Infectious Disease Consumption (2017-2022)
-
10.8.2 New Zealand Point of Care Infectious Disease Consumption (2017-2022)
11 Global Point of Care Infectious Disease Competitive Analysis
-
11.1 Siemens Healthineers
-
11.1.1 Siemens Healthineers Company Details
-
11.1.2 Siemens Healthineers Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Siemens Healthineers Point of Care Infectious Disease Main Business and Markets Served
-
11.1.4 Siemens Healthineers Point of Care Infectious Disease Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 F Hoffmann-La Roche Ltd
-
11.2.1 F Hoffmann-La Roche Ltd Company Details
-
11.2.2 F Hoffmann-La Roche Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 F Hoffmann-La Roche Ltd Point of Care Infectious Disease Main Business and Markets Served
-
11.2.4 F Hoffmann-La Roche Ltd Point of Care Infectious Disease Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Bio-Rad Labs Inc
-
11.3.1 Bio-Rad Labs Inc Company Details
-
11.3.2 Bio-Rad Labs Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Bio-Rad Labs Inc Point of Care Infectious Disease Main Business and Markets Served
-
11.3.4 Bio-Rad Labs Inc Point of Care Infectious Disease Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 OJ-Bio Ltd
-
11.4.1 OJ-Bio Ltd Company Details
-
11.4.2 OJ-Bio Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 OJ-Bio Ltd Point of Care Infectious Disease Main Business and Markets Served
-
11.4.4 OJ-Bio Ltd Point of Care Infectious Disease Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Thermo Fisher Scientific Inc
-
11.5.1 Thermo Fisher Scientific Inc Company Details
-
11.5.2 Thermo Fisher Scientific Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Main Business and Markets Served
-
11.5.4 Thermo Fisher Scientific Inc Point of Care Infectious Disease Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 bioMérieux SA
-
11.6.1 bioMérieux SA Company Details
-
11.6.2 bioMérieux SA Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 bioMérieux SA Point of Care Infectious Disease Main Business and Markets Served
-
11.6.4 bioMérieux SA Point of Care Infectious Disease Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 BD & Company
-
11.7.1 BD & Company Company Details
-
11.7.2 BD & Company Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 BD & Company Point of Care Infectious Disease Main Business and Markets Served
-
11.7.4 BD & Company Point of Care Infectious Disease Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Alere
-
11.8.1 Alere Company Details
-
11.8.2 Alere Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Alere Point of Care Infectious Disease Main Business and Markets Served
-
11.8.4 Alere Point of Care Infectious Disease Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Chembio Diagnostics Inc
-
11.9.1 Chembio Diagnostics Inc Company Details
-
11.9.2 Chembio Diagnostics Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Chembio Diagnostics Inc Point of Care Infectious Disease Main Business and Markets Served
-
11.9.4 Chembio Diagnostics Inc Point of Care Infectious Disease Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Trivitron Healthcare
-
11.10.1 Trivitron Healthcare Company Details
-
11.10.2 Trivitron Healthcare Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Trivitron Healthcare Point of Care Infectious Disease Main Business and Markets Served
-
11.10.4 Trivitron Healthcare Point of Care Infectious Disease Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Quest Diagnostics Inc
-
11.11.1 Quest Diagnostics Inc Company Details
-
11.11.2 Quest Diagnostics Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Quest Diagnostics Inc Point of Care Infectious Disease Main Business and Markets Served
-
11.11.4 Quest Diagnostics Inc Point of Care Infectious Disease Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Cardinal Health
-
11.12.1 Cardinal Health Company Details
-
11.12.2 Cardinal Health Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Cardinal Health Point of Care Infectious Disease Main Business and Markets Served
-
11.12.4 Cardinal Health Point of Care Infectious Disease Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Gene POC
-
11.13.1 Gene POC Company Details
-
11.13.2 Gene POC Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Gene POC Point of Care Infectious Disease Main Business and Markets Served
-
11.13.4 Gene POC Point of Care Infectious Disease Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Sight Diagnostics Ltd
-
11.14.1 Sight Diagnostics Ltd Company Details
-
11.14.2 Sight Diagnostics Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Sight Diagnostics Ltd Point of Care Infectious Disease Main Business and Markets Served
-
11.14.4 Sight Diagnostics Ltd Point of Care Infectious Disease Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Ortho-Clinical Diagnostics
-
11.15.1 Ortho-Clinical Diagnostics Company Details
-
11.15.2 Ortho-Clinical Diagnostics Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Main Business and Markets Served
-
11.15.4 Ortho-Clinical Diagnostics Point of Care Infectious Disease Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Trinity Biotech
-
11.16.1 Trinity Biotech Company Details
-
11.16.2 Trinity Biotech Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Trinity Biotech Point of Care Infectious Disease Main Business and Markets Served
-
11.16.4 Trinity Biotech Point of Care Infectious Disease Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Point of Care Infectious Disease Market Outlook by Types and Applications to 2028
-
12.1 Global Point of Care Infectious Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global HIV POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Clostridium difficile POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global HBV POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Pneumonia or Streptococcus associated infections Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Respiratory syncytial virus (RSV) POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global HPV POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Influenza/Flu POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global HCV POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global MRSA POC Consumption Forecast and Growth Rate (2022-2028)
-
12.1.10 Global TB and drug-resistant TB POC Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Point of Care Infectious Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Home Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Assisted Living Healthcare Facilities Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Point of Care Infectious Disease Market Analysis and Outlook to 2028
-
13.1 Global Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.2.2 Canada Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.2.3 Mexico Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.2 UK Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.3 Spain Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.4 Belgium Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.5 France Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.6 Italy Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.7 Denmark Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.8 Finland Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.9 Norway Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.10 Sweden Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.11 Poland Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.12 Russia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.3.13 Turkey Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.2 Japan Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.3 India Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.4 South Korea Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.8 Thailand Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.9 Singapore Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.11 Philippines Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.2 Colombia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.3 Chile Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.4 Argentina Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.6 Peru Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6.3 Oman Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6.4 Qatar Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.7.2 South Africa Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.7.3 Egypt Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.7.4 Algeria Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Point of Care Infectious Disease Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Point of Care Infectious Disease Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Point of Care Infectious Disease
-
Figure of Point of Care Infectious Disease Picture
-
Table Global Point of Care Infectious Disease Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Point of Care Infectious Disease Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global HIV POC Consumption and Growth Rate (2017-2022)
-
Figure Global Clostridium difficile POC Consumption and Growth Rate (2017-2022)
-
Figure Global HBV POC Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumonia or Streptococcus associated infections Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory syncytial virus (RSV) POC Consumption and Growth Rate (2017-2022)
-
Figure Global HPV POC Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza/Flu POC Consumption and Growth Rate (2017-2022)
-
Figure Global HCV POC Consumption and Growth Rate (2017-2022)
-
Figure Global MRSA POC Consumption and Growth Rate (2017-2022)
-
Figure Global TB and drug-resistant TB POC Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Home Consumption and Growth Rate (2017-2022)
-
Figure Global Assisted Living Healthcare Facilities Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Table North America Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure United States Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Canada Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Mexico Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure Germany Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure UK Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Spain Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Belgium Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure France Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Italy Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Denmark Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Finland Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Norway Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Sweden Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Poland Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Russia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Turkey Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table APAC Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure China Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure India Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Thailand Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Singapore Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Philippines Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table South America Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure Brazil Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Colombia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Chile Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Argentina Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Peru Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table GCC Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure Bahrain Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Oman Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Qatar Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table Africa Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure Nigeria Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure South Africa Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Egypt Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Algeria Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table Oceania Point of Care Infectious Disease Consumption by Country (2017-2022)
-
Figure Australia Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Point of Care Infectious Disease Consumption and Growth Rate (2017-2022)
-
Table Siemens Healthineers Company Details
-
Table Siemens Healthineers Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthineers Point of Care Infectious Disease Main Business and Markets Served
-
Table Siemens Healthineers Point of Care Infectious Disease Product Portfolio
-
Table F Hoffmann-La Roche Ltd Company Details
-
Table F Hoffmann-La Roche Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Point of Care Infectious Disease Main Business and Markets Served
-
Table F Hoffmann-La Roche Ltd Point of Care Infectious Disease Product Portfolio
-
Table Bio-Rad Labs Inc Company Details
-
Table Bio-Rad Labs Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Labs Inc Point of Care Infectious Disease Main Business and Markets Served
-
Table Bio-Rad Labs Inc Point of Care Infectious Disease Product Portfolio
-
Table OJ-Bio Ltd Company Details
-
Table OJ-Bio Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table OJ-Bio Ltd Point of Care Infectious Disease Main Business and Markets Served
-
Table OJ-Bio Ltd Point of Care Infectious Disease Product Portfolio
-
Table Thermo Fisher Scientific Inc Company Details
-
Table Thermo Fisher Scientific Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Point of Care Infectious Disease Main Business and Markets Served
-
Table Thermo Fisher Scientific Inc Point of Care Infectious Disease Product Portfolio
-
Table bioMérieux SA Company Details
-
Table bioMérieux SA Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table bioMérieux SA Point of Care Infectious Disease Main Business and Markets Served
-
Table bioMérieux SA Point of Care Infectious Disease Product Portfolio
-
Table BD & Company Company Details
-
Table BD & Company Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD & Company Point of Care Infectious Disease Main Business and Markets Served
-
Table BD & Company Point of Care Infectious Disease Product Portfolio
-
Table Alere Company Details
-
Table Alere Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere Point of Care Infectious Disease Main Business and Markets Served
-
Table Alere Point of Care Infectious Disease Product Portfolio
-
Table Chembio Diagnostics Inc Company Details
-
Table Chembio Diagnostics Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chembio Diagnostics Inc Point of Care Infectious Disease Main Business and Markets Served
-
Table Chembio Diagnostics Inc Point of Care Infectious Disease Product Portfolio
-
Table Trivitron Healthcare Company Details
-
Table Trivitron Healthcare Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trivitron Healthcare Point of Care Infectious Disease Main Business and Markets Served
-
Table Trivitron Healthcare Point of Care Infectious Disease Product Portfolio
-
Table Quest Diagnostics Inc Company Details
-
Table Quest Diagnostics Inc Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Inc Point of Care Infectious Disease Main Business and Markets Served
-
Table Quest Diagnostics Inc Point of Care Infectious Disease Product Portfolio
-
Table Cardinal Health Company Details
-
Table Cardinal Health Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health Point of Care Infectious Disease Main Business and Markets Served
-
Table Cardinal Health Point of Care Infectious Disease Product Portfolio
-
Table Gene POC Company Details
-
Table Gene POC Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gene POC Point of Care Infectious Disease Main Business and Markets Served
-
Table Gene POC Point of Care Infectious Disease Product Portfolio
-
Table Sight Diagnostics Ltd Company Details
-
Table Sight Diagnostics Ltd Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sight Diagnostics Ltd Point of Care Infectious Disease Main Business and Markets Served
-
Table Sight Diagnostics Ltd Point of Care Infectious Disease Product Portfolio
-
Table Ortho-Clinical Diagnostics Company Details
-
Table Ortho-Clinical Diagnostics Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ortho-Clinical Diagnostics Point of Care Infectious Disease Main Business and Markets Served
-
Table Ortho-Clinical Diagnostics Point of Care Infectious Disease Product Portfolio
-
Table Trinity Biotech Company Details
-
Table Trinity Biotech Point of Care Infectious Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trinity Biotech Point of Care Infectious Disease Main Business and Markets Served
-
Table Trinity Biotech Point of Care Infectious Disease Product Portfolio
-
Figure Global HIV POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clostridium difficile POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HBV POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumonia or Streptococcus associated infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory syncytial virus (RSV) POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HPV POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza/Flu POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HCV POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MRSA POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TB and drug-resistant TB POC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Assisted Living Healthcare Facilities Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Point of Care Infectious Disease Consumption Forecast by Country (2017-2022)
-
Table North America Point of Care Infectious Disease Consumption Forecast by Country (2017-2022)
-
Figure United States Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Point of Care Infectious Disease Consumption Forecast by Country (2017-2022)
-
Figure Germany Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Point of Care Infectious Disease Consumption Forecast by Country (2017-2022)
-
Figure China Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Point of Care Infectious Disease Consumption Forecast by Country (2017-2022)
-
Figure Brazil Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Point of Care Infectious Disease Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Point of Care Infectious Disease Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Point of Care Infectious Disease Consumption Forecast by Country (2022-2028)
-
Figure Australia Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Point of Care Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
